Human LBP PharmaGenie ELISA Kit (SBRS0825)

Quantify human Lipopolysaccharide-Binding Protein (LBP), a roughly 60 kDa acute-phase glycoprotein secreted by hepatocytes in response to bacterial infection, with this microplate-based quantitative immunoassay from Assay Genie. Because circulating LBP rises sharply after Gram-negative endotoxin exposure, it serves as an indirect readout of innate immune activation and is widely measured in studies of sepsis, endotoxemia, systemic inflammation, and acute-phase biology.

Configured for human reactivity, the Human LBP PharmaGenie ELISA Kit has been validated across serum, heparin plasma, citrate plasma, EDTA plasma, and cell culture supernatant matrices. Each kit includes a pre-coated microplate and reagents for 96 individual determinations, supporting medium-throughput workflows on a standard absorbance plate reader. Reconstituted standards and detection antibody should be aliquoted and stored at the temperatures specified in the product manual to limit loss across freeze-thaw cycles, while plates and working dilutions are equilibrated to room temperature before each run.

Researchers apply the kit to profile biomarker kinetics in infection models, screen anti-inflammatory compounds, and characterize acute-phase responses in clinical cohorts. The capture and detection antibody pair has been characterized for species specificity to human LBP, with cross-reactivity data against related acute-phase mediators documented in the product insert. Combined with quality-controlled standards and a ready-to-use protocol, the format offers a practical option for immunology, microbiology, and biomarker discovery laboratories.